mRNA Expression of TP53 Attenuates Survival of HPV plus Locally Advanced Head and Neck Cancer

被引：0
|
作者：
Aneja, S. [1 ]
Contessa, J. N. [1 ]
Husain, Z. A. [1 ]
Glazer, P. M. [2 ]
Hansen, J. E. [2 ]
Bindra, R. S. [1 ]
Yu, J. B. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2871
引用
收藏
页码：E350 / E351
页数：2
相关论文
共 50 条
  • [31] TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients
    Honorato, Beatriz
    Alcalde, Juan
    Martinez-Monge, Rafael
    Zabalegui, Natalia
    Garcia-Foncillas, Jesus
    GENE REGULATION AND SYSTEMS BIOLOGY, 2008, 2 : 63 - 70
  • [32] Locally advanced head and neck cancer
    Kies M.S.
    Bennett C.L.
    Vokes E.E.
    Current Treatment Options in Oncology, 2001, 2 (1) : 7 - 13
  • [33] Haplotype structure of TP53 locus in Indian population and possible association with head and neck cancer
    Mitra, S
    Chatterjee, S
    Panda, CK
    Chaudhuri, K
    Ray, K
    Bhattacharyya, NP
    Sengupta, A
    Roychoudhury, S
    ANNALS OF HUMAN GENETICS, 2003, 67 : 26 - 34
  • [34] TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection
    Klinakis, Apostolos
    Rampias, Theodoros
    EBIOMEDICINE, 2020, 58
  • [35] Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status
    Christian Issing
    Constantin Menche
    Mara Romero Richter
    Mohammed H. Mosa
    Jens von der Grün
    Maximilian Fleischmann
    Philipp Thoenissen
    Ria Winkelmann
    Tahmineh Darvishi
    Andreas G. Loth
    Shahram Ghanaati
    Franz Rödel
    Peter J. Wild
    Christian H. Brandts
    Timo Stöver
    Henner F. Farin
    Journal of Experimental & Clinical Cancer Research, 44 (1)
  • [36] TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
    Kuno, Ikumi
    Takayanagi, Daisuke
    Asami, Yuka
    Murakami, Naoya
    Matsuda, Maiko
    Shimada, Yoko
    Hirose, Sou
    Kato, Mayumi Kobayashi
    Komatsu, Masaaki
    Hamamoto, Ryuji
    Okuma, Kae
    Kohno, Takashi
    Itami, Jun
    Yoshida, Hiroshi
    Shiraishi, Kouya
    Kato, Tomoyasu
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [37] TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancer
    Ikumi Kuno
    Daisuke Takayanagi
    Yuka Asami
    Naoya Murakami
    Maiko Matsuda
    Yoko Shimada
    Sou Hirose
    Mayumi Kobayashi Kato
    Masaaki Komatsu
    Ryuji Hamamoto
    Kae Okuma
    Takashi Kohno
    Jun Itami
    Hiroshi Yoshida
    Kouya Shiraishi
    Tomoyasu Kato
    Scientific Reports, 11
  • [38] Immunohistochemistry biomarker TP53 expression predicts the survival of thymomas
    Bian, Dongliang
    Zhao, Liting
    Zhang, Xuelin
    Lv, Fanzhen
    Zhu, Zhenghong
    Qiu, Hui
    Zhang, Huibiao
    GLAND SURGERY, 2020, 9 (02) : 291 - +
  • [39] The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer
    Chen, Tseng-Cheng
    Wu, Chen-Tu
    Wang, Cheng-Ping
    Lou, Pei-Jen
    Ko, Jenq-Yuh
    Chang, Yih-Leong
    ORAL ONCOLOGY, 2020, 111
  • [40] Analysis of mutation and promoter methylation of TP53 gene in tumors of the head and neck
    Jarzynski, Adrian
    Papiernik, Katarzyna
    Polz-Dacewicz, Malgorzata
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2016, 29 (02) : 53 - 56
12345